India battles quality issues as generic drug demand rises

Headlines announcing a recall of drugs manufactured in India are commonplace, but the FDA intends to change that -- with support from Indian authorities. 

By Nicole Gray • June 4, 2014

Century-old testing procedure about to change

Researchers increasingly use genomics to guide their research, but active pharmaceutical ingredient testing is based on technology developed 100 years ago. That will be overhauled in 2015.

By Nicole Gray • June 4, 2014

Generic celecoxib approved in the US

Despite the black box warning on Celebrex (celecoxib), many patients find relief from arthritis and orthopedic pain with the drug. Recent FDA approval of generic celecoxib will now make that therapeutic relief less costly. 

By Nicole Gray • June 2, 2014

Report analyzes pros, cons of clinical research in 'BRIC' countries

The countries -- Brazil, Russia, India and China -- represent an opportunity for conducting clinical trials, Thomson Reuters reports. There are 30 million potential subjects, access to lab settings and well-educated healthcare professionals and manufacturing capabilities. But there are also challenges.

By Nicole Gray • May 29, 2014

Top analyst ranks 22 pharma firms based on R&D prowess

Bristol-Myers Squibb tops the list, compiled by analyst Richard Evans.

By Nicole Gray • May 27, 2014

Growing fear of MERS virus increases urgency of researchers

MERS has killed 181 people worldwide, but its appearance in the U.S. this month surprised authorities. Researchers at NovaVax are using a new method to develop vaccines, which could decrease the decade-long timeline and $1 billion cost associated with vaccine development.

By Nicole Gray • May 22, 2014

Roche expands manufacturing capacity as biologics revenues grow

Roche's oncology franchise continues to grow, with rapidly increasing revenues. To keep up with demand, the company is investing more than $1 billion in increasing manufacturing capacity, with the majority of the investment aimed at biologics manufacturing.

By Nicole Gray • May 19, 2014

Abbott seals deal to buy South American pharma company

Abbott is buying CFR Pharmaceuticals in Chile, with the goal of growing its portfolio, capacity and growth rate.

By Nicole Gray • May 19, 2014

Sun Pharma faces another massive drug recall

The company now has recalled three drugs in three months.

By Nicole Gray • May 16, 2014